Related references
Note: Only part of the references are listed.Human induced pluripotent stem cell (iPSC)-derived cardiomyocytes as an in vitro model in toxicology: strengths and weaknesses for hazard identification and risk characterization
Sarah D. Burnett et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2021)
Addressing variability in iPSC-derived models of human disease: guidelines to promote reproducibility
Viola Volpato et al.
DISEASE MODELS & MECHANISMS (2020)
A Bayesian Method for Population-wide Cardiotoxicity Hazard and Risk Characterization Using an In Vitro Human Model
Alexander D. Blanchette et al.
TOXICOLOGICAL SCIENCES (2020)
Toxicity testing in the era of induced pluripotent stem cells: A perspective regarding the use of patient-specific induced pluripotent stem cell-derived cardiomyocytes for cardiac safety evaluation
Li Pang
CURRENT OPINION IN TOXICOLOGY (2020)
An Open-Access Dataset of Thorough QT Studies Results
Barbara Wisniowska et al.
DATA (2020)
Thorough QT/QTc in a Dish: Can Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Predict Thorough QT Outcomes?
Hugo M. Vargas
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Clinical Trial in a Dish: Personalized Stem Cell-Derived Cardiomyocyte Assay Compared With Clinical Trial Results for Two QT-Prolonging Drugs
Ksenia Blinova et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2019)
Population-based toxicity screening in human induced pluripotent stem cell-derived cardiomyocytes
Sarah D. Burnett et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2019)
Thorough QT/QTc in a Dish: An In Vitro Human Model That Accurately Predicts Clinical Concentration-QTc Relationships
Alexander D. Blanchette et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
A primer on deep learning in genomics
James Zou et al.
NATURE GENETICS (2019)
Human iPSC banking: barriers and opportunities
Ching-Ying Huang et al.
JOURNAL OF BIOMEDICAL SCIENCE (2019)
Advancing chemical risk assessment decision-making with population variability data: challenges and opportunities
Weihsueh A. Chiu et al.
MAMMALIAN GENOME (2018)
A Human Population-Based Organotypic In Vitro Model for Cardiotoxicity Screening
Fabian A. Grimm et al.
ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION (2018)
Comprehensive Translational Assessment of Human-Induced Pluripotent Stem Cell Derived Cardiomyocytes for Evaluating Drug-Induced Arrhythmias
Ksenia Blinova et al.
TOXICOLOGICAL SCIENCES (2017)
Common genetic variation drives molecular heterogeneity in human iPSCs
Helena Kilpinen et al.
NATURE (2017)
A Tiered, Bayesian Approach to Estimating Population Variability for Regulatory Decision-Making
Weihsueh A. Chiu et al.
ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION (2017)
Taming Human Genetic Variability: Transcriptomic Meta-Analysis Guides the Experimental Design and Interpretation of iPSC-Based Disease Modeling
Pierre-Luc Germain et al.
STEM CELL REPORTS (2017)
CERAPP: Collaborative Estrogen Receptor Activity Prediction Project
Kamel Mansouri et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2016)
Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity
Paul W. Burridge et al.
NATURE MEDICINE (2016)
The Influence of Human Interindividual Variability on the Low-Dose Region of Dose-Response Curve Induced by 2,3,7,8-Tetrachlorodibenzo-p-Dioxin in Primary B Cells
Peter Dornbos et al.
TOXICOLOGICAL SCIENCES (2016)
Population-Based in Vitro Hazard and Concentration-Response Assessment of Chemicals: The 1000 Genomes High-Throughput Screening Study
Nour Abdo et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2015)
Evolving Electrocardiographic Changes in Lamotrigine Overdose: A Case Report and Literature Review
Patricia Chavez et al.
CARDIOVASCULAR TOXICOLOGY (2015)
Induced Pluripotent Stem Cells in Cardiovascular Drug Discovery
Mark Mercola et al.
CIRCULATION RESEARCH (2013)
A case series of patients with lamotrigine toxicity at one center from 2003 to 2012
P. W. Moore et al.
CLINICAL TOXICOLOGY (2013)
Quantitative High-Throughput Screening for Chemical Toxicity in a Population-Based In Vitro Model
Eric F. Lock et al.
TOXICOLOGICAL SCIENCES (2012)
How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines?
H. G. Laverty et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
In Vitro Screening for Population Variability in Chemical Toxicity
Shannon H. O'Shea et al.
TOXICOLOGICAL SCIENCES (2011)
Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects
Ruth Dixon et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Genetic Analysis of Human Traits In Vitro: Drug Response and Gene Expression in Lymphoblastoid Cell Lines
Edwin Choy et al.
PLOS GENETICS (2008)
Risk factors for prolonged QTc among US adults: Third National Health and Nutrition Examination Survey
SR Benoit et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2005)
Share Paper
